<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-07-16)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-07-16)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>AbbVie Licenses IGI Myeloma Candidate ISB 2001 for Up to $1.9B+</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-15</em></p>
<p>ISB 2001 is a first-in-class trispecific T-cell engager designed to target BCMA and CD38 on myeloma cells, as well as CD3 on T cells. ISB 2001 is envisioned as a competitor to several approved cancer-fighting drugs that target BCMA and CD3. The post AbbVie Licenses IGI Myeloma Candidate ISB 2001 ...</p>
<p><a href='https://www.genengnews.com/topics/cancer/abbvie-licenses-igi-myeloma-candidate-isb-2001-for-up-to-1-9b/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Global Neurodegeneration Proteomics Consortium Uncovers Biomarkers and Mechanisms</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-15</em></p>
<p>One of the world’s largest protein datasets offers new insights into the biological underpinnings of major neurodegenerative diseases according to research presented by the Global Neurodegeneration Proteomics Consortium. The post Global Neurodegeneration Proteomics Consortium Uncovers Biomarkers ...</p>
<p><a href='https://www.genengnews.com/topics/omics/global-neurodegeneration-proteomics-consortium-uncovers-biomarkers-and-mechanisms/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Rapid Pathogen Detection in Low-Resource Settings Using Open-Source RT-LAMP Assay</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-15</em></p>
<p>Researchers developed a lyophilized, heat-stable, open-source reverse transcription loop-mediated isothermal amplification assay that uses nonproprietary components, and offers an affordable molecular diagnostic tool for pathogen detection in diverse settings. The post Rapid Pathogen Detection in...</p>
<p><a href='https://www.genengnews.com/topics/infectious-diseases/rapid-pathogen-detection-in-low-resource-settings-using-open-source-rt-lamp-assay/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Cell Therapy in Cats Sheds Clues on Long COVID</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-15</em></p>
<p>Cats with feline infectious peritonitis (FIP), a severe coronavirus disease, experienced an immune system boost after treatment with a new mesenchymal stromal cell (MSC) therapy, opening translational avenues for humans. The post Cell Therapy in Cats Sheds Clues on Long COVID appeared first on GE...</p>
<p><a href='https://www.genengnews.com/topics/translational-medicine/feline-fever-cell-therapy-in-cats-sheds-clues-on-long-covid/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>$17.5B Deal Combines Waters with BD’s Biosciences and Diagnostics Business</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-07-15</em></p>
<p>Waters has projected the combined company would double its total addressable market (TAM) to approximately $40 billion, with more than 70% of the revenue expected to recur annually. Over half of the Waters-BD combination’s instrument revenue is expected to recur within a typical five- to ten-year...</p>
<p><a href='https://www.genengnews.com/topics/bioprocessing/17-5b-deal-combines-waters-with-bds-biosciences-and-diagnostics-business/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Serial acquirer Concentra Biosciences on a buyout spree in 2025</h3>
<p class='source-date'><em>Labiotech.eu • 2025-07-15</em></p>
<p>Concentra Biosciences is buying struggling biotechs and its portfolio has been growing rapidly in 2025. Learn about what it has been up to this past year. The post Serial acquirer Concentra Biosciences on a buyout spree in 2025 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unau...</p>
<p><a href='https://www.labiotech.eu/trends-news/concentra-biosciences-buyout-spree-2025/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<div class='news-item'>
<h3>Scientific mobility in microbiology – 4</h3>
<p class='source-date'><em>Trends in Microbiology • 2025-07-15</em></p>
<p>Leanid Laganenka</p>
<p><a href='https://www.cell.com/trends/microbiology/fulltext/S0966-842X(25)00186-6?rss=yes' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Scientific mobility in microbiology – 3</h3>
<p class='source-date'><em>Trends in Microbiology • 2025-07-15</em></p>
<p>Sitara S.R. Ajjampur</p>
<p><a href='https://www.cell.com/trends/microbiology/fulltext/S0966-842X(25)00185-4?rss=yes' target='_blank'>Read more</a></p>
</div>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Insight into on-site sewage facilities as an overlooked contributor to antimicrobial resistance: Environmental impacts and existing mitigation strategies.</h4>
<p class='source-date'><em>Ugolini Valentina, Khan Uzair Akbar, Löffler Paul et al. | Journal of environmental management • 2025-07-14</em></p>
<p><strong>Abstract:</strong> Antimicrobial chemicals and resistance genes (ARG) drive antimicrobial resistance (AMR) proliferation. Decentralized, on-site sewage facilities (OSSF), usually with small serving capacities, are commonly exempted from secondary treatment requirements. To date, dissemination of AMR contaminants fr...</p>
<p><a href='https://doi.org/10.1016/j.jenvman.2025.126528' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Optimizing Prevention of Recurrent Urinary Tract Infections in Older Patients with Frailty.</h4>
<p class='source-date'><em>Hjelholt Thomas J, Lietzen Lone Winther, Kongensgaard Rikke et al. | Drugs & aging • 2025-07-15</em></p>
<p><strong>Abstract:</strong> Frailty is associated with impaired immune function, functional decline, and increased vulnerability to both infection and adverse medication effects. Recurrent urinary tract infection (rUTI) is a common and burdensome condition among older persons, particularly those living with frailty. Despite...</p>
<p><a href='https://doi.org/10.1007/s40266-025-01230-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>16S rRNA and Metagenomic Datasets of Gastrointestinal Microbiota in Fetal and 7-Day-Old Goat Kids.</h4>
<p class='source-date'><em>Jiang Wenmeng, Xi Rongsheng, Zhou Junjuan et al. | Scientific data • 2025-07-15</em></p>
<p><strong>Abstract:</strong> The perinatal period (from late gestation to the neonatal stage) in ruminants is a critical phase for fetal organ maturation, where ecological succession of gastrointestinal microbial communities significantly impacts livestock production efficiency. However, research remains insufficient regardi...</p>
<p><a href='https://doi.org/10.1038/s41597-025-05555-y' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Alginate-based hydrogels loaded with human β-defensin-2 promote healing of MRSA-infected wounds in a diabetic model: a preclinical proof-of-concept study.</h4>
<p class='source-date'><em>Da Silva Jessica, Calheiros Daniela, Gonçalves Teresa et al. | Clinical and experimental medicine • 2025-07-15</em></p>
<p><strong>Abstract:</strong> Diabetic foot infections (DFIs), resulting from microbial colonization and proliferation in non-healing diabetic wounds, are among the most serious and common complications in patients with diabetes. As antimicrobial resistance continues to rise, the clinical management of DFI persists as a major...</p>
<p><a href='https://doi.org/10.1007/s10238-025-01798-6' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>An in vitro neurobacterial interface reveals direct modulation of neuronal function by gut bacteria.</h4>
<p class='source-date'><em>Lombardo-Hernandez Juan, Mansilla-Guardiola Jesús, Aucello Riccardo et al. | Scientific reports • 2025-07-15</em></p>
<p><strong>Abstract:</strong> Interactions between bacteria and somatic cells are increasingly important for understanding cellular communication mechanisms. While the gut microbiome's influence on the gut-brain axis is established, direct interactions between bacteria and neurons are poorly explored, especially regarding bid...</p>
<p><a href='https://doi.org/10.1038/s41598-025-10382-7' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<p>No recent papers on Synthetic & Molecular Biology available today.</p>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Efficacy of phage vB_Ps_ZCPS13 in controlling Pan-drug-resistant Pseudomonas aeruginosa from urinary tract infections (UTIs) and eradicating biofilms from urinary catheters.</h4>
<p class='source-date'><em>Mohamed Amira A, El-Zayat Emad M, El-Shibiny Ayman | Virology journal • 2025-07-12</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Pan-drug resistance (PDR) is a ticking time bomb, as it causes high human hospitalizations and mortality rates. For instance, Pseudomonas aeruginosa is associated with significant rates of urinary tract infections (UTIs) due to several reasons including antibiotic resistance, biofilm ...</p>
<p><a href='https://doi.org/10.1186/s12985-025-02848-x' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Phage engineering strategies to expand host range for controlling antibiotic-resistant pathogens.</h4>
<p class='source-date'><em>Zhang Song, Kim Jin-Chul, Ahn Juhee | Microbiological research • 2025-07-11</em></p>
<p><strong>Abstract:</strong> Bacteriophages are known as a promising alternative to control rising bacterial resistance. The adsorption phase is critical for the successful infection of phages, as it determines their ability to recognize and attach to specific bacterial host cells. However, their limited host ranges due to n...</p>
<p><a href='https://doi.org/10.1016/j.micres.2025.128278' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Innovative Non-antibiotic Strategies for Combating Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections.</h4>
<p class='source-date'><em>Nazari Mohsen, Bahrami Ali, Jahanian Faezeh | Current microbiology • 2025-07-14</em></p>
<p><strong>Abstract:</strong> Diabetic foot infections (DFIs) are a common and serious complication of diabetes mellitus (DM), often caused by methicillin-resistant Staphylococcus aureus (MRSA), which is challenging to treat due to its antibiotic resistance. The ability of MRSA to form biofilms and its resistance to commonly ...</p>
<p><a href='https://doi.org/10.1007/s00284-025-04349-0' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Phage and Endolysin Therapy Against Antibiotics Resistant Bacteria: From Bench to Bedside.</h4>
<p class='source-date'><em>Taati Moghadam Majid, Mohebi Samane, Sheikhi Raheleh et al. | MedComm • 2025-07-01</em></p>
<p><strong>Abstract:</strong> The rapid global spread of antibiotic-resistant bacteria presents a growing public health crisis, threatening the efficacy of existing antimicrobial treatments. As traditional antibiotics become increasingly ineffective, alternative therapies such as bacteriophages and endolysins have gained rene...</p>
<p><a href='https://doi.org/10.1002/mco2.70280' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Correction to: Coevolutionary phage training and Joint application delays the emergence of phage resistance in </h4>
<p class='source-date'><em> | Virus evolution • 2025-01-01</em></p>
<p><strong>Abstract:</strong> [This corrects the article DOI: 10.1093/ve/vead067.].</p>
<p><a href='https://doi.org/10.1093/ve/veaf053' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2025-07-16</em></p>
</div>
</body>
</html>